- Nachrichtendetail
-
26.04.2024 15:02:59 - dpa-AFX: *AMGEN TO SUBMIT MAA TO EMA FOR TEPROTUMUMAB IN THYROID EYE DISEASE TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Amgen | 867900 | NASDAQ | 314,410 | 21.05.24 21:29:07 | -0,130 | -0,04% | 314,390 | 314,460 | 314,410 | 314,540 |
